Address: Pronaos s.r.o. Libicka 1990/11 130 00 Prague 3,Czech Republic
Tel: +420 605 43 43 44
Pronaos is providing a broad range of consultancy services for business with:
– Medicinal Products
– Medical Devices
– Food Supplements
– Cosmetics
Our service ranges from product / task specific projects to the full establishment of new legal entities for our clients.The majority of our clients are active in the healthcare sector. We are also serving clients from other industries, e.g. the cosmetics industry. Pronaos has clients from all over Europe and our service covers country-specific, regional as well as pan-European projects.
Our clients are interested in a long-term and partnership based relationship, which allows to make Pronaos part of the implementation of their projects. The commitment for “hands-on” implementation is differentiating us from others. In addition, it is the basis allowing our clients to gain maximum value from our service.
The approach of Pronaos is project-based and result-orientated. According to the needs of the task, we work in high performing teams comprising members with extensive experience. With the knowledge and experience of our teams, we are able to serve our clients in a fast, flexible and impactful way. Complemented by a strong network of local and international partners, Pronaos delivers to its clients the results they are aiming for.
Our service ranges from product / task specific projects to the full establishment of new legal entities for our clients.
Dr. Sommermeyer, you’ve spent approximately two decades working for pharmaceutical companies throughout Europe. From a personal standpoint, why did you decide to leave the industry and found a consultancy? I…
A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic. Ripe for reform is the country’s orphan drug legislation as no standard pathway…
Jiří Lukeš, of B Braun Czech Republic, introduces the success of the affiliate he helped establish over 27 years ago, and why he feels that the local business is doing…
Petr Vaculík, country manager of PSI CRO, a privately owned Swiss clinical research organization (CRO), describes how the number of clinical trials is decreasing in the Czech Republic, although many…
Tamer Shawky, general manager Central Region for J&J Medical Devices, shares his first expectations arriving into the region three years ago, following a successful career in the Middle East and…
Olga Starobová, medical director of Syneos Health Czech Republic, walks us through the steps put in place to ensure successful synergies during the merger between INC Research and InVentiv Health,…
Kostas Deligiannis, general manager Eastern Europe for GE Healthcare (GEHC), outlines GE Healthcare’s commitment to the 20-country region under his remit, his priorities for greater collaboration between these countries, and…
Paul-François Cossa, country chair of Sanofi Czech Republic & Slovakia and General Manager CHC, reviews the outstanding performance of the company in 2019, breaks down his new vision for Sanofi…
Pavla Rozmarová, clinical research associate manager & regional OD for the Czech affiliate of German CRO Scope International, describes how the Czech clinical research landscape has evolved in the past…
Roman Badik, CEO of Enantis, the first biotechnology spin-off from Masaryk University in the Czech Republic, shares his vision of turning the company’s research breakthroughs into a self-sustaining business. Badik…
Augustin Bernát, general manager for the Czech affiliate of ResMed, a company whose cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases, discusses how…
Among the seven insurance funds in the Czech Republic, VZP is the largest with six million clients and the widest network of health service providers. David Šmehlík, the organisation’s deputy…
Martin Puchwein, country president for Novartis Group Czech Republic, and general manager for pharma, shares his perspectives on launching innovative drugs in the country, including some new therapeutic approaches such…
See our Cookie Privacy Policy Here
